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INTRODUCTION
Candida species are ubiquitous yeasts found as a part of normal flora of
mucocutaneous membranes and alimentary tract of humans. They cause
superficial mucosal infections usually, but can invade tissue and produce life
threatening pathology caused by alteration of immune defenses.
The major medical events that caused an increased incidence of
Candidial infections in the latter half of twentieth century where, i) introduction
of antibacterial agents with broad spectrum of activity that alters host’s normal
microbial flora in favour of fungal invasion and ii)increased prevalence of
immuno suppressed patients due to chemotherapy and emergence of Acquired
Immuno Deficiency Syndrome[1].
Candida species can cause wide range of clinical diseases ranging from
superficial infections of skin, nails and mucosal surfaces to deep seated
infections involving various internal organs to disseminated disease. It can
cause lower urinary tract infections and renal infection. Lower urinary tract
infection (UTI) is frequently seen in association with indwelling catheters and
Diabetes mellitus. Renal Candidiasis, characterized by microabcesses in cortex
can occur due to hematogenous spread.
Candida spp., the most prevalent opportunistic fungal pathogens of
urinary tract usually presents as nosocomial infection and rarely as community
acquired infection. About 10-15% of urinary tract hospital infections are due to
Candida spp and its prevalence is still increasing. Nosocomial UTIs were also
associated with a significant attributable mortality[2,3,4].
 
Risk factors comprise of the extensive use of broad spectrum
antimicrobial agents, corticosteroids, immunosuppressive agents, cytotoxic
chemotherapy complicated by mucositis and neutropenia, elderly age ,diabetes
mellitus, structural or functional abnormalities of urinary tract , indwelling
urinary catheter or nephrostomy. Increased incidence is observed in Chronic
Kidney Disease (CKD), patients on hemodialysis and Renal Transplant
recipients due to immunosuppression[5].
Candiduria is defined as the presence of Candida spp. in urine and
represents colonization or infection. Colonization refers to asymptomatic
adherence and settlement of yeast on catheters or other foreign bodies in
urinary tract. Candiduria, a marker of heavy colonization of urinary tract,
correlates with invasive disease significantly more than colonization of other
body sites .It should never be ignored, as it may be the only first and one of the
early indications of disseminated and invasive Candidiasis, especially in
critically ill patients. Candiduria was more frequent in the Candidemia due to
non-albicans Candida spp. than that due to Candida albicans [6,7].
Candida albicans accounts for 40-60% yeasts isolated in developed
countries, whereas Indian reports show an increased predominance of non
albicans Candida spp. The emergence of non-albicans Candida spp. may
represent selection of less susceptible species like C. glabrata and C. krusei .
C.glabrata is less susceptible and Candida krusei is intrinsically resistant to
Fluconazole. C. tropicalis has the highest adherence rate to inanimate materials
such as urinary and vascular catheters, and is often involved in biofilm
 
formation, that is more resistant to Antifungal agents. Resistance to Azoles in
C. tropicalis and C.albicans has also been increasingly reported [8,9,10].
There is also an increasing need for rapid speciation methods, as it can
also provide information on the susceptibility to Fluconazole and hence aid in
early treatment decisions.
Considering the above facts, the present study was conducted to speciate
Candida isolated from the urine of hospitalized patients, to correlate risk
factors associated and to find out the Antifungal susceptibility of the Candida
species isolated. A comparative analysis of rapid speciation method of Chrom
agar and conventional method of sugar fermentation was also carried out.
 
REVIEW OF LITERATURE
HISTORY
The history of Candida species is very old as the disease was described
in ancient times. Hippocrates in his “Epidemics” written 400 B.C described “In
the different ages the following complaints occur: To little and new-born
children, aphthae, vomiting, coughs, sleeplessness, frights inflammation of
navel, watery discharges from the ears.”; the first known description of
Candidal infections. Candidiasis has been recognized as a clinical entity since
then[12].
Anton Von Leeeuwenhock (1632-1723), was the first to report his
findings of bacteria, yeast and protozoa from scrapings from human mouth. In
1853, Charles Robin microscopically observed budding cells and filaments in
epithelial scrapings, and he named the fungus Oidium albicans. Subsequently,
more than 160 synonyms, including Monilia albicans, originated by Zopf in
1890, were used before Candida albicans became the accepted name for this
species[13,14].
Berkhout in 1923 restructured the genus Candida to encompass these
yeasts and this was accepted as the official name of the genus by Eighth
Botanical Congress held in Paris in 1954.Torulopsis, similar fungi known by
different names where brought into the domain by merging into the genus in
1978 and giving the new name Candida glabrata [12].
 
The incidence of yeast infection has increased in the last two decades.
Incidence of all forms of Candidal infections has risen abruptly. The increasing
incidence of Human Immunodeficiency Virus, use of therapeutic modalities for
advanced support, and certain surgical procedures, such as Organ
transplantation and implantation of prosthetic devices have continued to be
important in expanding the incidence of Candida infections. These
advancements have revived interest in fungal diseases and Candida infections
in particular[15,16].
Taxonomy: Genus Candida belongs to
KINGDOM: FUNGI
PHYLUM: ASCOMYCOTA
SUBPHYLUM: SACCHAROMYCOTINA
CLASS: HEMIASCOMYCETES
ORDER: SACCHAROMYCETALES
FAMILY: SACCHAROMYCETACEAE
Genus Candida consists of 200 anamorphic species and has teleomorphs
in ten different genera including Clavispora, Debaromyces, Issatchenkia,
Kluyveromyces ,Yarrowia and Pichia. [6] Common human pathogens are,
 
Candida Species and
Discoverer
Synonym Teleomorph
Candida albicans
(C.P. Robin) Berkhout 1923 [17]
Candida stellatoidea[18],
Oidium albicans[12] ,
Monilia albicans[12].
-
Candida dubliniensis
Sullivan et al.1995[19]
- -
Candida glabrata
Meyer & Yarrow 1978[20]
Torulopsis glabrata[16] -
Candida guilliermondi Yamadazyma
guilliermondii,Meyerozym
a guilliermondii.
Pichia
guilliermondii.
Candida kefyr
(Beijerinck) Van Uden &
H.R. Buckley (1970)
Candida
pseudotropicalis[12]
Kluyveromyce
s marxianus.
Candida krusei
(Castellani) Berkhout (1923)[21]
Candida castellani,
Saccharomyces krusei ,
Endomyces krusei ,
Monilia krusei.[22].
Issatchenkia
orientalis.
Candida lusitaniae Van Uden
& do Carmo-Sousa(1959) [23]
- Clavispora
lusitaniae.
Candida norvegensis Torulopsis norvegica.[11] Pichia
norvegensis[24]
Candida parapsilosis
(Ashford) Langeron and Talice,
1932
Monilia onychopila ,
Monilia parapsilosis,
Mycocandida parapsilosis.
-
Candida tropicalis
Berkhout, 1923[17]
Candida paratropicalis ,
Candida vulgaris ,
Monilia tropicalis ,
Oidium tropicale,
Mycotorula dimorpha,
-
Candida viswanathii Sandu &
H.S.Randhawa, 1962[20]
- -
 
Physiology
Candida spp metabolise glucose via the Hexose Monophosphate
pathway under aerobic conditions (assimilation) or via the Embden Meyerhof
pathway in anaerobiosis (fermentation). Mitochondrial oxidative
phosphorylation, Kreb’s cycle and protein synthesis are similar to those of
eukaryotic cells. Candida enzymes are significant as they may be directly
involved in pathogenesis.
Growth temperature has an important influence on morphogenesis.
Temperatures around 25°C promote the formation of chlamydospores in
C.albicans and higher temperatures around 37°C promote formation of
pseudohyphae[1].
Epidemiology
Fungi are ubiquitous in plants, mammals and insects .Humans are
continually exposed to numerous genera of fungi through a variety of routes.
Candida are normal commensals of humans and are commonly found on skin ,
throughout the entire gastrointestinal tract, in expectorated sputum, in female
genital tract and in urine of patients with indwelling Foley’s catheter[16,26].
Majority of these infections arise from an endogenous focus of
colonization, human to human transmission is also possible; the documentation
of nosocomial transmission or 'cross-infection' pose new and significant
problems. Recent studies indicate that Candida may be isolated from the hands
 
of 15-54% of health care workers in intensive care unit setting and is involved
in cross- infection [27].
Fungi represents the second most frequent causative organism of
nosocomial UTI ,ranging between 12% and 27% of total pathogens .Candida
spp. is responsible for 10-15% of nosocomial UTI. In healthy people, the
prevalence of Candiduria is as low as 0-0.3% and varies in hospital settings,
most prevalent in surgical ICU, leukemia and bone marrow transplant
units[28,29,30].
Risk to develop Candiduria was increased by twelve-fold after urinary
catheterization, six-fold after the use of broad spectrum antibiotics and
presence of urinary tract abnormalities, four-fold in abdominal surgeries, two-
fold in Diabetes mellitus and with corticosteroid administration. Diabetes
mellitus was the most common underlying disease in almost every study of
Candiduria. Candiduria is positively correlated with heavy colonization of the
urinary tract. Candiduria correlates with invasive disease significantly more
than colonization of other body sites[6,31,32,33].
Epidemiologic studies suggest that non-albicans Candida spp. are more
prevalent in urine compared to other sites of Candida infection like oropharynx
and vagina, possibly due to urine composition and or pH. However, these
microbiological differences remain unexplained currently. Mixed isolates were
found in 10% of patients with nosocomial Candiduria[29,32].Foreign studies on
Candiduria have reported C.albicans as the predominant causative organism,
where as Indian reports show an increased predominance of nonalbicans
 
Candida spp[31,34]. The emergence of nonalbicans Candida spp may represent
selection of more resistant species like C.glabrata and C.krusei[26,35,36].
PATHOGENECITY AND PATHOGENESIS
Normal Host Response: [37,38,39,40]
• Polymorphonuclear leucocytes damages pseuohyphae, phagocytoses
and kill blastospores.
• Monocytes, eosinophils and dendrocytes also ingest and kill
Candida.
• T- helper cells regulate phagocytosis.
• Serum heat stable and heat labile opsonins increase the rate of
ingestion; thereby B-lymphocytes and antibodies also have a role.
• Complement is necessary for optimal opsonisation of Candida
blastospores.
Pathogenesis
Infectious source of Candida is mostly endogeneous.
Gastrointestinal(GI) tract is considered to be a major reservoir for Candidiasis.
Damage to GI tract can help in the hematogenous spread. Candida can also
cross the intact GI tract by a ‘persorption’ and is due to fungal overgrowth due
to alteration of normal balance of bacterial flora following antibiotics [1].
 
Candida, being a human commensal to become a pathogen, interruption
of normal defense mechanism is necessary. Diabetes predisposes to cutaneous
Candidiasis .Introduction of antibiotics and widespread uses of indwelling
catheters are important iatrogenic factors predisposing to Disseminated
Candidiasis. Other therapeutic modalities like multiple abdominal surgeries,
Renal transplantation, neoplastic diseases, use of steroids and severe burns also
play an important role [38].
Differential expression of virulence factors including [1,41],
Adhesins: Helps fungi to attach adhere to host tissue and form biofilms.
Morphogenesis: Reversible transition between unicellular yeast cells
and filamentous growth forms helps in penetration to evade host’s defence
system.
Secreted Aspartyl Proteases, Phospholipases: Facilitate tissue
penetration and invasion.
Phenotypic Switching: Changes in antigen expression, colony
morphology and tissue affinities, helps in organism’s adaptation to the hostile
conditions.
Immunomodulatory effect: Contributes to reduced activity of host
defense system.
 
PATHOLOGY
Pathological and histopathological features of Candida infection is
highly variable, same organism can cause dissimilar pathological features in
patients whose immune system is intact and those who are immunosuppressed.
Pathological lesions are influenced by interaction of three factors, site of
infection, pathogenicity of infecting organism and competence of host immune
system [1].
SUPERFICIAL INFECTIONS:
It results from invasion of superficial layers of skin and or mucosa by
the organism. Macroscopically the lesion consists of a grayish plaque,
surrounded by edema, which on histopathological examination, consists of
infecting organism, neutrophils and cell debris. In deep ulcerative mucosal
lesions, as in immunosuppressed patients, the organism are present in the
submucosa and are disseminated hematogenously .The cellular reaction is
limited or absent and necrosis is accompanied by haemorrhage. Chronic
mucocutaneous Candidiasis is characterized by warty proliferation, due to
hyperkeratosis and epithelial hyperplasia[1].
DEEP INFECTIONS:
They are characterized by microabcesses, macroscopically they are
similar to miliary tuberculosis. They contain microorganism as blastospore and
or pseudohyphae, neutrophils, mononuclear cells and the abscess having a
necrotic center. Granulomata and giant cells are found in chronic lesion.
 
Kidneys seem to be the target organ for Candida presenting as nephritis,
pyelonephritis and rarely as papillary necrosis although liver, spleen and brain
may be affected in disseminated infections. Infection may be ascending or
hematogenous. Ascending infection is a sequel to prolonged catheterization and
broad spectrum antibacterial therapy .It is characterized by small white lesions
in medulla. When the spread is hematogenous, lesions are evenly distributed in
medulla and cortex and lesions in lower urinary tract are absent [1].
CLINICAL MANIFESTATIONS:
The spectrum of diseases caused by Candida has increased and
relatively large number of infections previously unrecognized or extremely
infrequent has become well documented now. They are subdivided into
mucous membrane, cutaneous and deep organ involvement [16].
Mucous membrane infection: Thrush, Candida oesophagitis, Non-
oesophageal gastro-intestinal Candidiasis, Candida vaginitis.
Cutaneous candidiasis syndrome: Generalized cutaneous Candidiasis,
Candida folliculitis, Erosion interdigitalis blastomycetica (Candida infection
between fingers or toes),Candida balanitis, Intertrigo, Paronychia ,
Onychomycosis, Diaper rash, Perianal candidiasis, Chronic Muco-cutaneous
Candidiasis ,Cutaneous lesions of disseminated Candidiasis.
Deep organ involvement: Central Nervous System Candidiasis,
Respiratory tract candidiasis, Cardiac Candidiasis(infection of pericardium,
myocardium and endocardium), Candida endocarditis, Urinary tract
 
Candidiasis, Candida arthritis, Osteomyelitis, Costocondritis and Myositis,
Candida infection of peritoneum ,liver, spleen and gall bladder, Candida
infection of vasculature, Ocular candidiasis, Neonatal candidiasis ,Syndrome of
disseminated Candidiasis and Candidemia [16].
Urinary tract candidiasis:
In the recent years there has been an increased proportion of Candida
among the nosocomial infections of which the largest increase was seen in
urinary tract infections showing an upsurge from 5% to 20% .Candida spp.
express a tropism for the kidney. Isolation of Candida spp. may represent a
superficial or deep infection of upper or lower urinary tract, vulvo-vestibular or
catheter colonization and contamination. Contamination of sample can be
excluded by repeating the urine culture. Colonization is a predisposing factor to
UTI and Candidemia[2,26,42].
PREDISPOSING FACTORS FOR CANDIDURIA:
Diabetes mellitus, indwelling urinary catheters, urinary tract disease,
prostatic hyperplasia, stones, recurrent urinary tract infection, posterior urethral
valve, antibiotics, immunosuppression ,transplant, extremes of age, female sex,
radiation therapy, cytotoxic chemotherapy, neutropenia, Chronic Renal Failure
and hemodialysis[43,44,45].
CANDIDURIA:
Candiduria refers to the presence of Candida species in urine. It is an
increasingly common finding in hospitalized patients. Most patients with
 
Candiduria are asymptomatic and patients with indwelling catheter are more
often colonized than infected with a Candida spp[2,46].
Ascending infection is the most common route of infection. Women are
most often affected due to shorter urethra and vulvo-vestibular colonization
with Candida spp. Urinary catheterization an important risk factor, allows
direct introduction or migration of organisms into bladder along the surface of
catheter. All catheters become colonized if left in-situ for a longer time.
Candida’s growth in urine is enhanced when urinary level of glucose exceeds
150mg/dl[2,44,47].
In contrast, hematogenous spread is one of the most important route for
renal candidiasis. This might be of outstanding importance because 90% of
patients with Candidemia who have died, had autopsy proven renal
involvement[48].
Unfortunately, colonization versus infection, lower urinary tract versus
upper urinary tract involvement and hematogeneous versus ascending infection
are very difficult to differentiate clinically. Pyuria is not predictive of infection,
it can be explained by mechanical injury of bladder mucosa by urinary catheter
and is frequently the result of coexistent bacteriuria[30,49].
Candiduria can be Asymptomatic, Lower Candidal UTI, Candidal
Cystitis and Upper Candidal UTI. Patients with Candiduria are at potential risk
for Invasive Candidiasis. It has been shown that 96% of patients are
asymptomatic and only 4%, complain of symptoms. No diagnostic tools are
available to readily differentiate between Candidial UTI and colonization [28,50].
 
Candiduria seems to correlate with invasive disease significantly, where
as absence of Candida in urine has nearly 100% negative predictive value for
systemic infection [6].
LAB DIAGNOSIS OF CANDIDURIA
Specimen collection: It has to be done under strict aseptic precautions,
as it can become easily contaminated with bacteria from vaginal canal,
perineum or indigenous flora in the urethra [51].
Specimens are to be collected in a wide mouthed sterile, leak-proof
screw capped container. Specimens collected are mid-stream urine specimens,
catheter collections, suprapubic aspiration and straight catheterized urine.
Suprapubic aspiration is reserved almost exclusively for neonates and small
children , a small incision is made with an 18 gauge needle over suprapubic
skin and 10ml of urine is aspirated into syringe [51].Straight catheterized urine is
more invasive and as urethral organisms can be introduced into the bladder
with catheter, this procedure is often not preferred [52]. Mid-stream urine and
catheter collections are the common specimens in adult patients.
Direct microscopic examination: It is highly useful for preliminary
screening .It is done on a wet film in high power objective .Wet mount can be
prepared. Gram’s stain of centrifuged urine is also done. Microscopic
examination will reveal budding yeast cell, pseudohyphae and leucocytes.
Yeast cells are approximately 4-8µm with budding and pseudohyphae[12,54].
 
Cultural characteristics: Isolation of yeast is done by culturing on
Sabouraud’s Dextrose Agar (SDA) with Chloramphenicol , Gentamicin and or
Tetracycline at 25°C and 37°C.It should be incubated for 48hrs, before a report
of no growth is given. They appear pasty, opaque, pale or white or off-white or
beige colored, often with a sweet smell reminiscent of ripe apples. A wet
mount and Gram’s stain should be made from cultures when colonies appear
[1,12,54,55]
.
Chrom Agar: A chromogenic differential culture medium is being
used to facilitate isolation and presumptive identification of clinically
important yeast species, especially Candida albicans.It is a rapid, plate based
method for simultaneous isolation and identification of species. It is based on
direct detection of specific enzymatic activities by adding certain substrates of
flurochromes to the media [12].
Corn-Meal Agar or Corn-Meal Tween 80 Agar: Cornmeal-tween 80
agar enhances the production of characteristic microscopic structures such as
chlamydospores. Dalmau plate culture is used to observe them. A heavy
inoculum of yeast is streaked across the plate containing medium and coverslip
is placed over it. The streak should extend beyond the cover slip. Plates are
incubated for 48hrs at 25°C.The edge of the coverslip is observed under low
power objective as chlamydospores are seen maximum in this area.
These are helpful in presumptive identification, differentiating
organisms with identical biochemical profiles and as quality control check of
species identification in automated kits[12,51,55].
 
Germ-tube test:A portion of yeast colony is inoculated into 0.5 ml of
rabbit or human plasma or serum and incubated at 35ºC for 2 hours. A drop of
yeast and serum suspension is placed on a microscope slide, overlaid with a
coverslip and seen for the presence of germ tubes .Germ tube is a filamentous
extension and it is half the width and three- four times the length of the mother
cell. No constriction is seen where the germ tube emerges from the yeast. Germ
tubes are formed in C.albicans and C.dubliniensis. Not all strains of C.albicans
produce germ tube. The procedure is used for presumptive identification of
C.albicans .The demonstration of germ tube is known as Reynolds Braude
phenomenon [12,51,55].
Biochemical tests: The genus Candida and different Candida spp. can
be characterized by the pattern of utilization of carbohydrate and nitrogen
substances. Candida spp. can utilize carbohydrates oxidatively called
assimilation and anaerobically called fermentation.
Carbohydrate fermentation: Liquid medias are supplemented with
different carbohydrates,a colour indicator to detect pH changes due to acid
production and Durham’s tube to detect gas production[1].
Carbohydrate Assimilation: The classical Wickherham and Burton
method assessed the ability of the yeast isolate to grow in a minimal liquid
media supplemented with carbohydrates. As it was laborious and time
consuming, it was replaced by auxanographic technique of Hazen and Howell
in 2003, in which minimal media agar plates, Yeast Nitrogen Agar Base (YNB
without a carbohydrate source) on which paper discs impregnated with
different carbohydrates are placed. Assimilation can be determined by the
 
ability of the yeast to grow around carbohydrate disc. Commercial systems to
determine assimilation of 20 carbon substrates have now been introduced [1,56].
Nitrate assimilation test: Yeast carbon agar with addition of various
nitrogen sources tests the ability of yeast to assimilate nitrogen. Peptone and
potassium nitrate are used as nitrogen test sources. It can be determined by the
ability of the yeast to grow around potassium nitrate and peptone disc in Yeast
Carbon Agar [57].
Immunodiagnosis:
Detection of Candida antigens: Candida antigens like mannans,
cytoplasmic antigens like enolase and glycoprotein can be detected by Enzyme
ImmunoAssays, Radio ImmunoAssay and Latex agglutination tests using
monoclonal antibodies [56].
Detection of Candida antibodies: Antibodies to Candida antigens
released or expressed during deep seated infection like enolase and heat shock
proteins, can be determined by Immunodiffusion(ID), Counterimmune
electrophoresis (CIE), Enzyme Linked Immune Sorbent Assay(ELISA) or
Latex agglutination(LA) test. Low sensitivity occurs due to a less sensitive test
or due to poor immune status of patients. Antimannan antibodies are normally
found in healthy individuals and superficial infection [56].
Other methods: [1, 12]
Detection of Proteinase : Auxanographic methods.
 
Detection of Fungal Metabolites: Fungal metabolites like D-arabinitol
and D-mannose in serum and urine are detected by Gas-Liquid
Chromatography & Enzymatic fluorometric assessments.
Molecular Techniques: It includes PCR using DNA probes or rRNA
probes, Restriction fragment length polymorphism, Southern hybridization
pattern, Electrophoretic patterns of DNA,RNA profiling.
ANTIFUNGAL SUSCEPTIBILITY TESTING:
It has become important in the Clinical Laboratory due to
i. The increased incidence of fungal infections during the last 15 yrs,
ii. The more frequent and prolonged use of both established and
investigational Antifungal agents;
iii. The increased awareness of the emergence of resistant organisms to
established Antifungal agents; and
iv. The need to develop a reliable database to document the relationship
between the in vitro result and the clinical outcome of therapy to
define ultimate utility of Antifungal Susceptibility testing[58].
Standardization of in vitro susceptibility tests by the Clinical Laboratory
Standards Institute (CLSI) and the European Committee for Antimicrobial
Susceptibility Testing (EUCAST) were highly useful[59].
BROTH BASED METHODS
 
1. Macrobrothdilution method: This was the first method proposed by
CLSI.As it was too cumbersome, it was replaced by Microbroth Dilution
method. M27-A2 standard is the document intended for testing yeasts by
using either a Macro or MicroBroth Dilution test system.
2. Microbroth dilution: It recommends the use of RPMI-1640 medium
(with glutamine, phenol red, without bicarbonate) supplemented with
0.2% glucose and buffered to a pH of 7.0 with 0.165 mol/L MOPS
buffer. Antifungal drugs are added to the wells in serial dilutions as
recommended by CLSI. Inoculum standardized to 0.5 McFarland’s is
added and incubated at 35°C. Plates are read at 24 hours. The wells
should be visualized with a reading mirror and the growth in each well
should be compared with that of the growth control. The MIC for
Amphotericin B is lowest concentration which is optical clear and for
Azoles, 5-Fluorocytosine MIC are lowest concentrations with a
prominent reduction in turbidity [60].
3. Spectrophotometric method:It is a more objective measurement of
yeast growth than subjective visual assessment, and affords a simpler
,more reliable basis for data analysis than visual scoring of turbidities on
a 1+ to 4+ scale. This method provides a better reproducibility, good
agreement with CLSI method [61].
4. Sensititre Yeast One Test Panel /Fungitest: A MicroBroth Dilution
method based on the CLSI M27-A2 standard. It consists of a disposable
microtitre plate with dried serial dilutions of Antifungal agents in wells.
The wells contain Alamar Blue, a redox indicator as colorimetric
 
indicator. End point is read by a colour change from blue to pink. MIC
results when compared with CLSI method showed favorable results
[62,63,64]
.
5. Flow Cytometry : Assay for Antifungal Susceptibility testing by measuring
the impairment of fungal metabolic activity. Yeast viability analyzed by Flow
Cytometry with a fluorescent probe, FUN-1, which emits a red fluorescence
when yeast is metabolically active. This method yielded reliable results[65].
AGAR BASED METHODS
1. Disk diffusion: The M44-A standard is a newly established
methodology for disk diffusion testing of Candida species. The standard
includes zone interpretive criteria for Fluconazole and Voriconazole. It
recommends the use of Mueller-Hinton Agar supplemented with 2%
glucose and 0.5 ug/ml methylene blue dye medium. Mueller-Hinton agar
is readily available, with acceptable batch-to-batch reproducibility,
glucose provides a suitable growth for most yeasts and the addition of
methylene blue enhances the zone edge definition. Inoculum is
standardized to 0.5 McFarland’s and plates should be incubated at 35 ºC
for 24 hours [60].
2. Etest: An agar diffusion method using a strip with a predefined
concentration gradient of the antimicrobial agent being tested, that
allows for MIC determination. It is done on modified RPMI-1640 agar
supplemented with 0.2% glucose. Etests are simple to perform with
 
reasonable correlation to CLSI standard. Resistant isolates need to be
confirmed by CLSI methodology [67,68].
3. Neo-Sensitabs: A simple agar diffusion method using tablets to
determine the susceptibility of fungi with a Biomic plate reader to
electronically read and interpret zone sizes. Resistant isolates need to be
confirmed by CLSI methodology [63,64].
TREATMENT OF CANDIDURIA
Asymptomatic Candiduria:
• Risk factors are to be modified, which includes removal of catheter,
control of Diabetes and discontinuation of antibiotics.
• It is treated in Renal transplant recipients , low-birth weight infants
,patients who have or had neutropenia and prophylaxis in patients
undergoing invasive urological procedure as follows,
Fluconazole 200mg/day orally for 7-14 days or
Amphotericin B, 50mg/l for bladder irrigation or 0.3mg/kg IV or
5-Flucytosine, 150mg/kg/day for 7-14 days.
Candida cystitis:
• Fluconazole 200mg/day orally for 7-14 days.
Ascending pyelonephritis:
• Surgical drainage,
 
• Fluconazole 6mg/kg/day for 2-6 weeks,
• Amphotericin B IV >0.6mg/kg /day or Caspofungin 50mg/day for
2-6 weeks.
Renal candidiasis:
• Fluconazole 6mg/kg/day for 2-6 weeks,
• Amphotericin B IV > 0.6mg/kg /day or Caspofungin 50mg/day for
2-6 weeks[2,3].
ANTIFUNGAL RESISTANCE: [26]
It is divided into (i) Clinical resistance and (ii) Cellular or In-vivo
resistance.
I) Clinical Resistance, is a result of low level of drugs in serum and or
tissues caused by poor patient adherence, drug interaction that decreases
antifungal levels and in patients with severe immuno-suppression like
AIDS.
II) Cellular or In-Vivo Resistance, is independent of host and involves
strains less responsive to Antifungal agents at standard doses .It can be
primary or secondary resistance. Primary or intrinsic resistance is
demonstrated by organisms that are naturally resistant to Antifungals.
Examples include C.krusei intrinsically resistant to fluconazole,
replacement of original isolate by more resistance strain or more
resistant species, genetic alteration resulting in a more resistant strain
 
and transient gene expression resulting in a temporary resistance.
Secondary or acquired resistance occurs when initially susceptible
isolate becomes resistant to an Antifungal agent .It is commonly
encountered in HIV positive patients.
Mechanisms of resistance: [26]
Azole resistance: It is due to
• Changes in sterol components of plasma membrane,
• Genetic changes in ERG11 gene encoding Lanosterol demethylase,
• Alteration of enzymes involved in Ergosterol biosynthesis and
• Drug efflux mechanisms.
Amphotericin B resistance: Poorly understood, it is probably due to
changes in sterol components of plasma membrane and lipid composition of
cell membrane.
Flucytosine resistance: Deficiency of cytosine permease, cytosine
deaminase, UMP pyrophosphorylase and loss of feedback regulation leading to
increased synthesis of pyrimidines.
Echinocandin resistance : Due to mutations in FKS genes encoding 1,3
β-D glucan synthase.
 
AIMS AND OBJECTIVES
• To speciate the Candida isolates from urine of hospitalized patients.
• To find out the ratio of Candida albicans to non-albicans Candida
species.
• To correlate the risk factors to the Candida species associated.
• To compare the speciation of Candida isolates using the rapid technique
of Chrom agar with the conventional techniques of sugar fermentation
and sugar assimilation tests.
• To find out the antifungal susceptibility of the Candida species isolated.
 
MATERIALS AND METHODS
• Design of the study: Cross-sectional study.
• Study period: Oct 2010 –Sept 2011.
• Place of Study: Institute of Microbiology, Madras Medical College &
Rajiv Gandhi Government General Hospital, Chennai.
• Ethical considerations: Approved by Institutional Ethics Committee,
Madras Medical College & Rajiv Gandhi Government General Hospital,
Chennai.
• Statistical analysis: Statistical analysis was carried out using statistical
package for social sciences and episoftware by Statistician. The proportional
data were tested using Pearson’s Chi Square Analysis test and Fischer’s exact
test.
• Study group: Study group included 100 hospitalized patients with
Candiduria having a colony count of more than 10 4/ml of urine.
Inclusion criteria:
• Hospitalized Patients with urine colony count of any Candida species
more than or equal to 10 4/ml.
• Patients older than 12 yrs of age.
• Both males and females were included.
 
Exclusion Criteria:
• Candiduria with colony counts less than 10 4/ml of urine.
• Patients less than 12 yrs of age.
• Outpatients.
Patients satisfying the inclusion criteria were included in the study and
after getting informed consent, they were assigned serial numbers. They were
interviewed by structured questionnaire and their hospital records were used to
know about the history, risk factors, duration of Candiduria and treatment
details.
SPECIMEN COLLECTION
Urine Specimens were collected in a wide mouthed, sterile, leak-proof
screw capped container. Specimens collected were mid-stream urine
specimens, and catheter collections. They were immediately transported to
laboratory without any delay, as urine is an excellent culture medium. Delay of
more than 1-2 hr in transportation if unavoidable, it should be stored in
refrigerator at 4°C or transported in a container with 1.8% boric acid [54].
Mid-stream urine specimen: Urine samples are commonly collected by this
technique. The peri-urethral and perineal areas are first cleansed with gauze
pads soaked in soapy water. The labia should be held apart during voiding in
females and in males, the foreskin is retracted, if uncircumcised .The first few
milliliters of urine passed into a bed pan or toilet bowl to flush the bacteria
from urethra. The mid-stream portion is then collected into the container [51,68].
 
Catheter Collections:The area is disinfected before proper collection of
samples. Urine samples are aspirated using a sterile syringe and needle (gauge
no.28), through a soft rubber connecter between catheter and collecting tubing.
Urine samples should not be collected from catheter bags and catheter tips are
also not suitable for culture as they can be contaminated with urethral or
colonizing organisms [51,69].
SPECIMEN PROCESSING:
Direct microscopical examination:
Microscopic visualization of uncentrifuged urine was done. One to three
Candida per high power field was found to be equivalent to colony count of
approximately 15000/ml with 80% accuracy. A wet mount of uncentrifuged
urine was done. A small volume of urine was applied to a glass microscope
slide, allowed to air dry, stained with Gram’s stain, and examined
microscopically for presence of gram positive budding yeast cells with or
without pseudohyphae[1,70].
Each patient’s urine was transferred into sterile centrifuge tubes and
then centrifuged at 3000rpm for 10-15 minutes. The supernatant was discarded
and the deposit examined microscopically by Gram’s stain for yeast cells,
budding cells and pseudohyphae [71, 72].
Culture: [12,73,74]
 
• The uncentrifuged mid-stream urine was cultured on blood agar, Mac
Conkey agar, Cystine lactose electrolyte deficient (CLED) agar and
Sabouraud’s Dextrose Agar (SDA) for primary isolation of Candida
spp.
• All the plates were incubated at 37°C .SDA was incubated at 25°C and
37°C. The plates were read at 24 and 48 hrs after incubation.
• Colonies were cream colored, pasty and smooth. A wet mount, lacto
phenol cotton blue (LPCB) mount and Gram’s stain were done from the
culture isolates to confirm it as Candida species.
CANDIDA SPECIES MACROSCOPIC FEATURES[55]
C.albicans and C. dubliniensis Colonies are cream coloured, pasty and
smooth.
C.tropicalis Colonies are cream to off-white in
colour, glistening to dull,soft, smooth or
wrinkled with a mycelia fringe.
C. kefyr Creamy , dull ,soft and smooth colonies.
C. krusei Flat, dull, dry and wrinkled colonies.
C. parapsilosis Creamy colonies developing in a lacy
pattern.
C.guillermondii Thin ,flat, glossy,cream to pink, smooth
or wrinkled colonies.
C. glabrata Glistening, smooth, cream coloured
colonies.
 
Colony count:
• Colony counts were carried out using 10-fold serial dilutions of
uncentrifuged urine in normal saline, ranging from 1 in 101to 1 in 106.
Urine samples were spread by calibrated loops onto Sheep blood agar.
• Loop was touched in the centre of plate from which the inoculum was
spread across the diameter of the plate. Loop was then drawn across the
entire plate, crossing the first inoculums streak numerous times to
produce isolated colonies.
• Dilution factors and loop factor were then multiplied to get the final
colony count per ml of urine[52,73,75].
SPECIES IDENTIFICATION: The various Candida spp. were
identified based on the following tests.
CANDIDA SPECIES MICROSCOPIC FEATURES[55]
C. albicans ,C.parapsilosis Ovoid,elliptical or round blastoconidia
seen .
C. guillermondii ,C. tropicalis Ovoid or elliptical blastoconidia seen.
C. kefyr ,C. krusei Elongated, slender oval blastoconidia
seen.
 
Germ tube test:
• A small portion of an isolated colony was suspended in a test tube
containing 0.5 ml of rabbit or human plasma or serum.
• The test tube was incubated at 37°C for 2 hours.
• A drop of yeast suspension was placed on a microscope slide, overlaid
with a coverslip and examined microscopically for the presence of germ
tubes which are long tube like projection from yeast cells.
• Isolates producing germ tubes were presumptively identified as
C.albicans or C.dubliniensis[12,51,54].
Growth at 42°C:
• Germ tube positive isolates were subcultured to SDA and incubated at
42°C.
• Isolates of C.albicans grow, while C.dubliniensis do not grow at 42°C
[76]
.
Surface growth:
• A colony was inoculated into Sabouraud’s Dextrose broth and incubated
at 30°C for 48hrs.
• C.tropicalis, produces a pellicle at the broth surface.
 
• C.krusei, grows as a climbing film on the sides of the glass[54].
Candida HI-CHROM agar:
• Yeast isolates were subcultured twice onto Sabouraud’s Dextrose Agar
to ensure isolation of pure colonies.
• Isolates were plated directly from SDA to HI-Chrom agar.
• The plates were then incubated at 30°C for 48 hours. Color readings
were made after 48 hours of incubation.
• The various species of Candida were identified by their colony color,
size, texture, and presence of color diffusion into the surrounding agar
presumptively in 48hrs[12,49,77,78].
Candida species Colour on HI-Chrom agar
C. albicans Light green colour colonies.
C. dubliniensis Dark green colonies.
C. tropicalis Steel blue colonies with a pink halo.
C. glabrata Pink to Purple colonies.
C. parapsilosis Cream colored colonies.
C. guilliermondii Cream to Pale pink or purple colonies.
C. krusei Pale pink, dry rough colonies with spreading, pale
edges.
 
Corn meal agar (Dalmau plate culture technique):
• Inoculating loop was loaded with test organism from primary culture
media.
• Three parallel cuts were made 1/4inches or 1 cm apart on the surface of
Cornmeal agar, by holding the inoculating wire at 45 degree angle.
• A cover-slip was laid on the surface of agar, covering a portion of
inoculated streaks.
• Plates were incubated at 30°C for 24-48 hours in moisturized chamber.
• Plates were examined by placing it in a microscope whose slide carrier
is removed and pattern of growth like Chlamydospores, hyphae,
pseudohyphae and their relationship was observed.
CANDIDA SPECIES MORPHOLOGY ON CORNMEAL AGAR
C. albicans Blastoconidia, pseudohyphae and large, thick
walled, terminal chlamydospores present.
C. dubliniensis Terminal chlamydospores are abundant.
C. tropicalis Ovoid blastoconidia anywhere along pseudohyphae.
C. krusei Chains of blastoconidia at junction of pseudohyphal
cells, with a characteristic ‘crossed matchstick’
appearance.
C. parapsilosis Short,curved pseudohyphal cells develop into giant
cells.
C. kefyr Elongated blastoconidia at junction of pseudohyphal
cells, separate from pseudohyphae and lie parallel to
it, with a “log jam” arrangement.
C. guillermondii Blastoconidia at constrictions of pseudohyphae.
 
It is helpful in making a presumptive identification and is not
confirmatory. Chlamydospores production by C.albicans is diagnostic [51,54,55].
Sugar fermentation test:
• A suspension of pure colony of yeast from sugar free media was made in
sterile distilled water equivalent to McFarland’s opacity standard of 4
and 0.2ml of suspension was inoculated to a 2% sugar fermentation
media with an indicator.
• Dextrose, sucrose, lactose and maltose were tested.
• They were incubated at 48-72hrs at 30°C and further incubated up to 1
week.
• The ability to ferment sugars was identified by presence of acid
production and gas trapped in durham’s tube.
Fermentative yeasts produce carbon dioxide and alcohol .pH may not
change and therefore gas production is itself indicative of fermentation
[54,79,80,81,82]
.
Sugar assimilation test/ Auxanographic Procedures
• The medium yeast nitrogen base (YNB) without the carbohydrate source
was used. Agar was autoclaved at 121°C.
 
• YNB was added at 6.7gm/100ml of distilled water and sterilized by
filtration.
• Heavy yeast suspension made from two to three colonies of the 24-48
hr culture grown in a sugar free media was added to 2ml of YNB
prepared . It was emulsified to turbidity equal to McFarland’s 4 units.
• The YNB & yeast suspension was added to 18ml of molten agar cooled
at 45°C, gently swirled to distribute the yeast cells in the molten agar,
and the entire volume was poured into a 90mm petri plate.
• Sugar discs should be placed in a circle with sterile forceps, such that at
least 30mm was present between centers of each disc and incubated at
30°C for 24-48 hrs.
• If the sugar was assimilated, a zone of growth appears around the disc
[81,83,84]
.
ANTIFUNGAL SUSCEPTIBILITY TESTING:
Antifungal Susceptibility Testing for Candida isolates was done by,
• Disc diffusion method, as per CLSI Guidelines on Antifungal
Susceptibility testing in M-44A document.
• Microbroth dilution technique as per CLSI Guidelines on
Antifungal Susceptibility testing in M-27A2 document.
Disc diffusion method:
 
Medium: Mueller Hilton Agar with 2% glucose and 0.5 µg methylene
blue dye adjusted to a pH of 7.2-7.4was used.
Inoculum preparation:
• Organisms were subcultured and incubated at 35°C to ensure purity and
viability.
• Inoculum was prepared by direct colony suspension method. Five
colonies of approximately 1 mm diameter from a 24-hour old culture
was picked and suspended in 5 ml of sterile normal saline.
• Suspension was vortexed and adjusted spectrophotometrically at 530 nm
to 0.5 McFarland’s standard containing, 1x 106 to 5 x 106 cells/ml.
Inoculation of test plate
• Sterile cotton swab stick was dipped into suspension, rotated several
times and pressed firmly against the inside wall of the tube above fluid
level to remove excess fluid.
• It was streaked evenly over the entire agar surface 3 times, rotating each
time at an angle of 60°C, to ensure an even distribution of inoculum.
Application of disks to inoculated plates
• Antimicrobial discs were dispensed onto the surface of an inoculated
agar plate by means of a sterile forceps and pressed down.
 
• The discs were evenly distributed on the plate with a distance of 2.5 cm
from centre to centre of the discs.
• Plates were inverted and incubated at 37°C within 15 minutes.
Reading and Interpretation: [81,85]
• Results were read at 20-24 hours, when semi-confluent growth had
formed. In case of insufficient growth, it was read at 48 hours.
• Zone of inhibition was measured at the point where there is prominent
reduction in growth.
• QC strains used to ensure quality control were ,
Candida albicans ATCC 90028 and Candida tropicalis ATCC 750.
Zone diameter, (nearest whole in mm)
Antifungal agents,
Disc content Resistant
Susceptible –
Dose
Dependent
Sensitive
Fluconazole,25µg <14mm 15-18mm >19mm
Itraconazole,10µg < 11mm 12-19mm >20mm
AmphotericinB,100U <10mm Not applicable >10mm
The interpretive criteria for the Fluconazole disk test were those
published the CLSI guidelines M44. Break points for Itraconazole (10µg) and
Amphotericin B (100U) are not available. The response was interpreted
 
according to the study by Negri et al [87].A quality control was performed in all
batches in accordance with the CLSI document M27-A2 by using QC strains.
Microbroth dilution technique:
Antifungal agents: They were obtained from reputed company,
Pharma-Fabricon as pure salt, with details of potency as µg /international units
per mg of powder.
Standard solution of an antifungal agent can be prepared by calculating
the weight of the powder by, Target volume of stock solution (mg) X Desired
concentration (µg/ml) /Potency(µg/mg).
Volume of Solvent is calculated by, Weight of Powder (mg) X
Potency(µg/mg) /Desired concentration(µg/ml).
Solvents for preparing stock solutions of Antifungal agents include,
Dimethylsulfoxide (DMSO) for Amphotericin B and Itraconazole and water
for Fluconazole.
• For Antifungal agents soluble in water, stock solutions were prepared at
ten times the highest concentration to be tested.
• For Antifungals insoluble in water, stock solutions were prepared at
hundred times the highest concentration to be tested.
• A series of dilution at 10 or 100 times final dilution were also prepared
to avoid dilution artifacts due to precipitation of compounds.
 
• For Amphotericin B ,Itraconazole the drug concentration ranged from
0.0313 to 16 µg/ml so stock solution was prepared from 03.13 to 1600
µg/ml.
• For Fluconazole, the drug concentration ranged from 0.125 to 64 µg/ml
so stock solution was prepared from 1.25 to 640 µg/ml.
Broth medium and buffer:
RPMI 1640 with glutamine, without bicarbonate with phenol red as
indicator was the media used. It was buffered to pH 7.0 at 25°C with MOPS ,3-
N-morpholino propane sulphonic acid buffer to a final concentration 0.165
mol/l .
Inoculum preparation:
• All isolates were subcultured twice into SDA at 35°C to ensure purity
and viability.
• Inoculum was prepared by picking up 5 colonies of <1mm diameter
from a 24 hr old culture and suspended in 0.85% saline. The resulting
suspension was vortexed and cell density was adjusted to 0.5 Mc
Farland’s standard at 530nm with a spectrophotometer. This yielded
about 1X106 to 5X106 cells/ml.
• A working suspension was made by 1 in 1000 dilution with RPMI 1640
broth medium.
 
• This inoculum was diluted 1:1, then wells were inoculated to achieve a
final desired inoculums size with a final concentration of 5X102 to
2.5X103 cells per ml.
Procedure:
• The test was performed in a sterile, disposable,96 well microdilution
plate using standard RPMI 1640.
• From the various dilutions of stock solution (10 X drug concentration),
working dilutions were prepared at 2 X drug concentration with
RPMI1640 and was dispensed into the wells of row 1 to10 of the
microdilution plate using a pipette. Row 1 contains the highest drug
concentration and row 10 contains the lowest drug concentration.
• Each well was inoculated with 100µl of 2 X final inoculum suspension,
which brings the inoculum and drug dilutions to final concentration.
• Growth control well contains 100µl of sterile drug free medium with
100µl of 2 X inoculum suspension.
• Row 11 was used to perform the sterility control containing the drug
free medium only.
• Quality control strains were also tested. Plates were incubated at 35° C
for 48 hrs.
 
Reading and Interpretation:
MIC was detected by the amount of growth in the well containing the
agent was compared with the amount of growth in the control well. A
numerical score from 0 to 4 was given to each well using following scale [12] ,
Score 0 Optically clear.
Score 1 Slightly hazy.
Score 2 Prominent reduction in turbidity.
Score 3 Slight reduction in turbidity.
Score 4 No reduction in turbidity.
Amphotericin B:
MIC was read as the lowest drug concentration in which a score of 0,
optically clear was observed.
Azoles:
MIC was read as the lowest drug concentration in which a score of 2
with prominent decrease in turbidity was observed. A slight turbidity can occur
above the MIC and is identical for all drug concentration above the MIC.
Allowable turbidity was estimated by diluting 0.2ml of drug free growth
control with 0.8ml of media, producing an 80% inhibition standard[12,60].
 
INTERPRETIVE CRITERIA FOR MICROBROTH DILUTION
TECHNIQUE[60]
Antifungal agents,
range of dilutions
used in MBD
Sensitive
Susceptible –
Dose
Dependent
Resistant
Fluconazole,
0.125 to 64 µg/ml
< 8 µg/ml 16-32 µg/ml >64µg/ml
Itraconazole,
0.0313 to 16 µg/ml
< 0.125 µg/ml 0.25-0.5 µg/ml >1µg/ml
Amphotericin B,
0.0313 to 16 µg/ml
<1µg/ml Not applicable >1 µg/ml
 
RESULTS
This cross-sectional study was carried out during the period of October
2010 to September 2011 in the Institute Of Microbiology, Madras Medical
College, Chennai. Speciation of isolates from 100 hospitalized patients with
Candiduria was done and their Antifungal Susceptibility testing was done by
Disk Diffusion and Microbroth Dilution technique.
Table 1
AGE DISTRIBUTION OF THE STUDY POPULATION
Age (Years) Total no of cases
n=100 no (%)
Male
n=56 no (%)
Female
n=44 no (%)
<20 4(4%) 3(5.4%) 1(22.7%)
20-29 19(19%) 6(10.7%) 13(29.5%)
30-39 15(15%) 7(12.5%) 8(18.2%)
40-49 19(19%) 10(17.9%) 9(20.5%)
50-59 16(16%) 12(21.4%) 4(9.1%)
>60 27(27%) 18(32.1%) 9(20.5%)
Total 100(100%) 56(100%) 44(100%)
Majority of the study population belonged to the above 60years age
group (27%), followed by (19%) patients in 20-29 & 40-49 years age group.
Females predominated in the age group of 20-29 yrs (29.5%), where as males
predominated after 60 yrs (32.1%).
 
Table 2
TYPE OF PRESENTATION OF CANDIDURIA IN MALES AND
FEMALES IN VARIOUS AGE GROUPS
Age Group(Years)Type
of
presen
tation,
n(%)
<20 20-29 30-39 40-49 50-59 >60
T =1(1%) T=6(6%) T=2(2%) T=3(3%) T =3(3%) T=12(12%)
Sympt
omatic
patient
s 27
(27%)
M
1
(1%)
F
-
M
2
(2%)
F
4
(4%)
M
1
(1%)
F
1
(1%)
M
2
(2%)
F
1
(1%)
M
2
(2%)
F
1
(1%)
M
11
(11%)
F
1
(1%)
T =1(1 %) T =4(4%) T =8(8%) T =10(10%) T =11(11%) T=8(8%)Asymp
tomati
c
patient
s
42(42
%)
M
0
(0%)
F
1
(1%)
M
2
(2%)
F
2
(2%)
M
4
(4%)
F
4
(4%)
M
5
(5%)
F
5
(5%)
M
9
(9%)
F
2
(2%)
M
4
(4%)
F
4
(4%)
T =2(2%) T =9(9%) T =5(5%) T =6(6%) T =2(6%) T=7(7%)*Unconscious
patient
s
31(31
%)
M
2
(2%)
F
-
M
2
(2%)
F
7
(7%)
M
2
(2%)
F
3
(3%)
M
2
(2%)
F
4
(4%)
M
1
(1%)
F
1
(1%)
M
4
(4%)
F
3
(3%)
Total
100 4(4%) 19(19%) 15(15%) 19(19%) 16(16%) 27(27%)
T-Total,M-Male,F-Female
Most of the patients had asymptomatic Candiduria (42%), followed by
symptomatic patients (27%) and Unconscious patients who were unable to tell
the symptoms (31%). Symptomatic and unconscious patients were common in
the age group of > 60yrs, were as asymptomatic patients were common in the
age group of 40-49yrs and 50-59yrs.
 
Table 3
PRESENTATION OF VARIOUS SYMPTOMS IN PATIENTS WITH
CANDIDURIA
SYMPTOMS Male,
n=56,no (%)
Female,
n=44, no (%)
TOTAL,
n=100 no (%)
Fever 12(21.4%) 4(9.1%) 16(16%)
Dysuria 9(16%) 2(4.5%) 11(11%)
Increased
frequency
7(12.5%) 2(4.5%) 9(9%)
Urgency 7(12.5%) 1(2.3%) 8(8%)
Lower
abdominal pain
6(10.7%) 1(2.3%) 7(7%)
Incontinence 5(8.9%) 1(2.3%) 6(6%)
Back pain 2(3.6%) 3(6.8%) 5(5%)
Urinary
retention
5(8.9%) 0(0%) 5(5%)
Among the patients with Candiduria fever (16%), dysuria (11%) were
the predominant symptoms. Symptoms of frequency,urgency were present in
9%, 8% respectively and lower abdominal pain in 7% of patients. Dysuria,
increased frequency and lower abdominal pain were predominant in males than
in females.
 
Table 4:
INFECTION IN SYMPTOMATIC PATIENTS WITH CANDIDURIA
DISEASES No (%)
Pyelonephritis 5(18.5)
Cystitis 3(11.1)
Lower UTI 19(70)
Total, n 27(100)
Lower UTI was common in 19(70%), followed by Pyelonephritis in
5(18.5%) and Cystitis in 3(11.1%) of the symptomatic patients with
Candiduria.
 
Table 5
WARD DISTRIBUTION & THE RISK FACTORS IN PATIENTS WITH
CANDIDURIA
WARD, number of patients Major risk factor associated & no (%)
Medicine, n=35 Diabetes mellitus-26(74)
Antibiotic -25 (71)
Catheterization-22(63)
Nephrology, n=17 CKD & diseases of urinary tract-17(100)
Antibiotics-14(82)
ICU(Intensive Care Unit),
n=12
Antibiotic-12(100)
Catheterization -12(100)
Urology, n=10 CKD, other diseases of urinary tract-
10(100)
Catheterization-10(100)
Antibiotic -8(80)
Surgery, n=14 Antibiotic-13(93)
Catheterization-13(93)
Neurosurgery, n=6 Catheterization-6(100)
Prolonged antibiotic -6(100)
Immunosupressives (steroids)-5(100)
Orthopedics, n=3 Catheterization-3(100)
Prolonged antibiotic -3(100)
Geriatrics, n=2 Catheterization-2(100)
Rheumatology, n=1 Catheterization-1(100)
Diabetes mellitus -1(100)
Immunosupressives(steroids)-1(100)
Patients from Medical ward had Diabetes mellitus as a major risk factor,
were as patients from Urology and Nephrology had diseases of urinary tract as
the major risk factors.ICU and Surgery, Orthopedics, Neurosurgery patients
had antibiotic use and catheterization as major risk factor .In addition,
immunosuppressives were a major risk factor for Neurosurgery patients.
 
Table 6
RISK FACTORS IN CANDIDURIA DUE TO C. ALBICANS AND NON
ALBICANS CANDIDA SPP.
Candiduria due to C.albicans
n =14
Candiduria due to nonalbicans Candida
spp. n=91
Risk factors, no of
patients
TOTAL
no (%)
MALE
no(%)
FEMALE,
no (%)
TOTAL
no(%)
MALE
no (%)
FEMALE
no(%)
Prolonged
antibiotics,82
11(78.6) 6(43) 5(36) 71(78) 38(42) 33(36)
Catheterization,73 6(42.9) 3(21) 3(21) 67(73.6) 39(43) 28(31)
Diabetes mellitus,43 6(42.9) 4(29) 2(14) 37(40.7) 22(24) 15(17)
Chronic kidney
disease,34
3(21.4) 1(7) 2(14) 31(34) 18(20) 13(14)
Unconsciousness,33 2(14.3) - 2(14) 31(34) 14(15) 15(17)
Immunosuppressives,
27
3(21.4) 1(7) 2(14) 24(26.4) 13(14) 10(11)
Surgery,17 2(14.3) 2(14) - 15(16.5) 9(10) 6(7)
Hemodialysis ,15 2(14.3) - 2(14) 13(14.3) 9(10) 4(4)
Other Renal
diseases,13
2(14.3) - 2(14) 11(12) 2(2) 9(10)
ICU stay,12 2(14.3) - 2(14) 10(11) 4(4) 6(7)
Renal transplant,8 1(7.1) 1(7) - 7(7.7) 5(6) 2(2)
Other candidiasis
(oral,esophageal),5
- - - 3(3.3) 3(3) -
Use of antifungals,3 - - - 3(3.3) 3(3) -
HIV reactive,2 - - - 2(2.2) - 2(2)
Neurogenic bladder,2 - - - 2(2.2) 2(2) -
*Other renal diseases- Acute Renal Failure, Tuberculosis of Kidney, RPGN-Rapidly
Progressive Glomerulonephritis, Phimosis, Hypospadiasis, Calculi, Prostatomegaly,
Phimosis, Carcinoma Prostate.
Major risk factors included antibiotics use in 82%, catheterization of
urinary tract in 73%, followed by diabetes in 43% and Chronic Kidney Disease
in 32% of the patients with Candiduria. Nonalbicans Candida spp was more
common in catheterized patients (73.6%) and unconscious patients(34%).
 
Table 7
DISEASES OF URINARY TRACT IN PATIENTS WITH CANDIDURIA
Risk factor Total, n=100 no
(%)
Male, n=56
no (%)
Female, n=44
no(%)
Chronic kidney
disease
34(34) 19(34) 15(34)
Acute renal failure 4(4) 1(1.8) 3(6.8)
Calculi 3(3) 2(3.6) 1(2.3)
Neurogenic bladder 2(2) 2(3.6) -
Renal tuberculosis 1(1) - 1(2.3)
RPGN 2(2) - 2(4.5)
Prostatomegaly
(BPH)
3(3) 3(5.4) NA
CA Prostate 1(1) 1(1.8) NA
Phimosis 1(1) 1(1.8) NA
Hypospadiasis 1(1) 1(1.8) NA
BPH-Benign Prostatic Hypertrophy, NA-Not applicable
Chronic Kidney Disease was the major risk factor among the diseases of
urinary tract, accounting for about 34% of patients with Candiduria followed
by Renal Transplantation in 8% of patients. Neurogenic bladder and Calculi
were more common in males, while RPGN and TB were common in females.
 
Table 8
TYPE OF URINE SAMPLES
Type of sample
Received
Total, n=100 no
(%)
Male, n=56
no (%)
Female, n=44
no(%)
Catheterized urine 73(73) 42(75) 31(70.5)
Mid- stream urine 27(27) 14(25) 13(29.5%)
Suprapubic aspiration 0(0) - -
Total 100(100) 56(100) 44(100)
73 % of urine samples were catheterized urine samples followed by
27% of midstream urine samples. 75% of samples from males and 70.5% of
samples from females were catheterized urine samples.
 
Table 9
DISTRIBUTION OF CANDIDA ALBICANS AND NON-ALBICANS
SPECIES AMONG PATIENTS WITH CANDIDURIA
SPECIES NO PERCENTAGE
Candida albicans 14 13.3%
Nonalbicans Candida
species
91 86.7%
Total 105 100%
Candida albicans accounted for only 13.3% of all Candida spp isolated,
where as nonalbicans Candida spp. accounted for 86.7% among patients with
Candiduria.
 
Table 10
DISTRIBUTION OF CANDIDA SPECIES AS SINGLE AND MIXTURE
ISOLATE
Candida Species Single isolate, n=95
no (%)
Mixture
isolates, n=10
no (%)
Total,
n=105 ,no
(%)
C. tropicalis 64(67.4) 3(30) 67(63.8)
C. albicans 13(13.7) 1(10) 14(13.3)
C.guillermondii 8(8.4) 0(0) 8(7.6)
C.krusei 3(3.2) 5(50) 8(7.6)
C. parapsilosis 6(6.3) 0(0) 6(5.7)
C. kefyr 1(1.1) 1(10) 2(1.9)
C. glabrata - - -
Total 95(100) 10(100) 105 (100)
Of the 105 isolates, 67 belonged to C.tropicalis, 14 isolates were
C.albicans, followed by 8 isolates of C.guillermondii & C. krusei each. Six
isolates of C. parapsilosis and 2 isolates of C. kefyr were also isolated.
C.tropicalis was predominant among the single isolates (67.4%), where as
C.krusei (50%) was predominant among mixture isolates.
 
Table 11
DISTRIBUTION OF MIXTURE ISOLATES OF CANDIDA SPECIES
AMONG PATIENTS WITH CANDIDURIA
Mixture species no Percent
C.krusei& C.tropicalis 3 60%
C. krusei & C.albicans 1 20%
C. krusei & C.kefyr 1 20%
TOTAL n=5 100%
C. krusei with C. tropicalis were the predominant mixtures (60%)
obtained. C.krusei was found in all the mixture isolates.
 
Table 12
DISTRIBUTION OF CANDIDA ISOLATES AMONG CATHETERIZED
AND MID-STREAM URINE SAMPLES
Species & Total
no of isolates(%)
Total no of
isolates, n=105
no (%)
No of isolates in
Catheterized
samples, n=76 no
(%)
No of isolates
in Mid-stream
urine, n=29 no
(%)
C.albicans 14(13.3) 5(6.6) 9(31.3)
C.tropicalis 67(63.8) 52(68.4) 15(51.7)
C. guillermondii 8(7.6) 6(7.8) 2(6.9)
C. krusei 8(7.6) 6(7.8) 2(6.9)
C. parapsilosis 6(5.7) 5(6.6) 1(3.4)
C. kefyr 2(1.9) 2(2.6) 0(0)
C. glabrata - - -
Total 105(100%) 76(100%) 29(100%)
C.albicans was more common in mid stream urine (51.7%) sample than
from catheterized urine samples. C.tropicalis was more common in
catheterized urine samples (68.4%) than from midstream urine samples
(51.7%).
 
Table 13
COMPARISON OF METHODS OF CANDIDA SPECIATION
SPECIES, NO
OF ISOLATES
Sugar Assimilation,
n(%)
Sugar Fermentation,
n(%)
Hi-chrom agar,
n(%)
C.tropicalis,67 67(100%) 67(100%) 58(86.5%)
C. albicans,14 14(100%) 13(92.9%) 13(92.8%)
C. guillermondii,8 8(100%) 8(100%) 7(87.5%)
C.krusei,8 8(100%) 8(100%) 8(100%)
C. parapsilosis,8 6(100%) 6(100%) 6(100%)
C.kefyr,2 2(100%) 2(100%) 0(0%)
Assimilation was the best method of Candida speciation as it identified
all the Candida species (100%), followed by fermentation which identified all
the species, except one isolate of C.albicans. The ability of Hi-Chrom agar to
identify the species varied greatly from 86.5% to 100% in different species.
 
Table 14
SENSITIVITY OF HI-CHROM AGAR FOR VARIOUS SPECIES OF
CANDIDA
Species, no of
isolates
Correctly
identified by HI-
Chrom agar
Wrongly
Identified by
HI-Chrom agar
Sensitivity
C.tropicalis,67 58 9 86.5%
C.albicans,14 13 1 92.8%
C.guillermondii,8 7 1 87.5%
C.krusei,8 8 0 100%
C.parapsilosis,6 6 0 100%
C.kefyr,2 0 2 0%
C. glabrata,0 - - -
Total=105 92 13 87.6%
Hi media-Chrom agar was highly sensitive for detection of
C.parapsilosis (100%) and C.krusei (100%), less sensitive for C.tropicalis
(86.5%) & C.guillermondii (87.5%). Of the 105 isolates, only 92 were
identified, with an overall sensitivity of 87.6%.
 
Table 15
SPECIFICITY, PREDICTIVE VALUES OF THE COLOURS ON HI-
CHROM AGAR
COLOURS ON Hi-CHROM AGAR
SPECIES,CO
LOUR OF
COLONIES
& (n) LG DG BL CR DP PP-PU PUR
SPECIF
ICITY PPV NPV
Steel blue
,C.tropicalis
(67)
7 2 58 0 0 0 0 97.4% 98.3% 80%
Light green ,C.
albicans (14)
13 0 1 0 0 0 0 92.8% 65% 98.9%
Pale pink to
purple
colonies,
C.guillermondi
i (8)
0 1 0 0 0 7 0 100% 100% 99%
Dry pink,
C.krusei, (8)
0 0 0 0 8 0 0 100% 100% 100%
Cream,
C.parapsilosis
(6)
0 0 0 6 0 0 0 100% 100% 100%
Purple,
C.glabrata, (0)
- - - - - - - - - -
Colonies- LG-Light Green, DG-Dark Green, BL-steel blue, CR –Cream, DP-
dry,pink, PP- PU-pale pink to purple, PUR-purple,PPV-Positive predictive
value, NPV-Negative predicitive value
Chrom agar was highly specific for C.guillermondii ,C.parapsilosis and
C.krusei (100%) than those of C.albicans (92.8%) and C.tropicalis (97.4%).
 
Table 16
ANTIFUNGAL SUSCEPTIBILITY TO FLUCONAZOLE
SUSCEPTIBLE n(%) <
8 µg/ml
SUSCEPTIBLE
DOSE DEPENDENT
n(%),16-32 µg/ml
RESISTANT n(%) >64
µg/mlSPECIES AND
NUMBER OF
ISOLATES(n)
DD MBD DD MBD DD MBD
C.tropicalis(67) 46(68.7%) 48(71.6%) 6(8.9%) 4(5.9%) 15(22.4%) 15(22.4%)
C. albicans(14) 10(71.4%) 12(85.7%) 2(14.3%) - 2(14.3%) 2(14.3%)
C.guillermondii(8) 7(87.5%) 7(87.5%) - - 1(12.5%) 1(12.5%)
C.krusei(8) - - - 8(100%) 8(100%)
C.parapsilosis(6) 5(83.3%) 5(83.3%) 1(16.6%) 1(16.6%) - -
C.kefyr(2) 2(100%) 2(100%) - - - -
C. glabrata(0) - - - - - -
TOTAL(105) 70(67%) 74(70.5%) 9(8.6%) 5(4.7%) 26(24.7%) 26(24.7%)
DD-Disk Diffusion method, MBD-Microbroth Dilution technique
By Disk Diffusion, 70(67%) isolates were sensitive and 26(24.7%)
isolates were resistant to Fluconazole, whereas by Microbroth Dilution
technique 74(70.5%) isolates were sensitive and 26(24.7%) were resistant.
 
Table 17
ANTIFUNGAL SUSCEPTIBILITY TO ITRACONAZOLE
SUSCEPTIBLE n(%)
< 0.125 µg/ml
SUSCEPTIBLE DOSE
DEPENDENT
n(%)0.25-0.5 µg/ml
RESISTANT n(%) >1
µg/mlSPECIES AND
NUMBER OF
ISOLATES (n)
DD MBD DD MBD DD MBD
C.tropicalis(67) 48(71.6%) 53(79.1%) 5(7.4%) 6(8.9%) 14(20.9%) 8(11.9%)
C. albicans(14) 8(57.1%) 10(71.4%) 2(14.2%) 2(14.2%) 4(28.6%) 2(14.2%)
C. guillermondii
(8) 7(87.5%) 7(87.5%) - - 1(12.5%) 1(12.5%)
C.krusei(8) 5(62.5%) 5(62.5%) - 1(12.5%) 3(32.5%) 2(25%)
C. parapsilosis
(6) 6(100%) 6(100%) - - - -
C.kefyr(2) 2(100%) 2(100%) - - - -
C. glabrata(0) - - - - - -
TOTAL(105) 76(72.4%) 83(79.1%) 7(6.7%) 9(8.6%) 32(30.5%) 13(12.4%)
DD-Disk Diffusion method, MBD-Microbroth Dilution technique
79.1% of the Candida isolates were sensitive, 8.6% were susceptible
dose dependent and 12.4% were resistant to Itraconazole by Microbroth
Dilution technique.
 
Table 18
ANTIFUNGAL SUSCEPTIBILITY TO AMPHOTERICIN B
SUSCEPTIBLE n(%)
< 1µg/ml
RESISTANT n(%)
>1 µg/ml
SPECIES AND
NO OF
ISOLATES
DD MBD DD MBD
C.tropicalis,67 61(91.7%) 67(100%) 6(8.9%) -
C. albicans,14 12(85.7%) 14(100%) 2(14.2%) -
C .guillermondii,8 6(75%) 8(100%) 2(25%) -
C.krusei,8 5(62.5%) 8(100%) 3(37.5%) -
C. .parapsilosis,6 5(83.3%) 6 (100%) 1(16.67%) -
C.kefyr,2 2(100%) 2(100%) - -
C.glabrata,0 - - - -
TOTAL(105) 91(86.7%) 105(100%) 14(13.3%) -
DD-Disk Diffusion method, MBD-Microbroth Dilution technique.
All the isolates were highly sensitive (100%) to Amphotericin B by
MBD.
 
Table 19
DISCREPANCIES IN DISK DIFFUSION & MICROBROTH
DILUTION
Antifungal Minor error Major error Very major
error
Fluconazole 4 (3.8%) - -
Itraconazole 12(11.4%) 2(1.9%) -
Amphotericin B - 14(13.3%) -
• Minor error-Shifts between Susceptible and SDD or Resistant and SDD
by DD and MBD.
• Major error-Resistant by DD but Susceptible by MBD.
• Very Major Error- Sensitive by DD but Resistant by MBD.
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DISCUSSION
A significant rise in prevalence of Urinary Tract Infections(UTI) due to
Candida spp. has occurred over the last 20 years with the surge of non albicans
Candida spp. Clinical importance of species level identification is important as
they differ in expression of virulence factors and Antifungal susceptibility.
Current study was undertaken to speciate the Candida isolated from
urine samples of hospitalized patients and to find their Antifungal susceptibility
pattern. The study also concentrated on the changes observed in species
distribution, the shift towards nonalbicans Candida spp. in our hospital.
The present study showed predominance of patients in the age group of
>60 yrs (Table1) contributing to about 27% of total patients, followed by
patients in 19% in 40-49 yrs and 20-29 yrs. This correlated well with the
previous study by S.Krcmery et al, were the mean age was 62.4 yrs[5].
Males contributed to 56% (Table1) of the study population. This was
similar to the results of study by Arlene O.Cantillep et al [87]. Although there is
an increased risk in female gender, the other associated risk factors like
Diabetes, CKD, Prostatomegaly, Carcinoma prostate were common in males in
our study.
Female population predominated in 20-29 yrs and 30-39 yrs, probably
because of increased vaginal colonization in the sexually active population, use
of contraceptive devices , contraceptive pills and poor genital hygiene in low
socioeconomic group. High levels of reproductive hormones provide a greater
 
amount of glycogen in the vagina, further providing a good source of carbon
for Candida growth. It was demonstrated that estrogens increases the affinity
for the vaginal epithelial cell adherence of Candida and Yeast cytosol receptor
or system to connect to reproductive hormones that increase the formation of
yeast blastopores[88].
An important observation was that about 42% (Table 2) of patients with
Candiduria were asymptomatic; an important complicating factor in defining
Candiduria, as many patients on long term catheterization cannot vocalize on
symptoms of dysuria or increased frequency. Asymptomatic patients were
common in the age groups 40-49 and 50-59 yrs. Of the 42 patients with
asymptomatic Candiduria, 30 were on antibiotics and 29 patients were
catheterized.
Only 13% of patients in one large multicenter study by Mauricio
Carvalho et al in 2001, had symptoms suggesting UTI. Current study showed
the symptomatic Candiduria in 27% (Table 2) of patients. Symptoms of UTI
were predominant in the age group of > 60 yrs and were more common in
males. The predominance was probably because of increase in associated risk
factors in the older age group.
In the present study, about 31% (Table 2) of patients were unconscious
and on prolonged catheterization. So these patients could not be categorized
either as symptomatic or asymptomatic patients. About 10 of the 12 ICU
patients, 5 of 6 neuro-surgery patients and 10 patients from medical ward were
unconscious. These patients had associated risk factors like catheterization and
prolonged antibiotic use.
 
Fever was the most common presenting symptom in 16 % of patients
with Candiduria followed by dysuria in 11% (Table 3). This was lesser than the
results of the study by Paul A Tambyah et al[89], where in fever was present in
17.7% patients and dysuria in 6% of catheterized patients with UTI . Tambyah
et al’s study population was that of both bacterial and fungal infections in
catheterized patients, were as the current study included only patients with
Candiduria. Catheterization also makes the patient asymptomatic, as the
presence of a catheter in the urethra prevents continuous exposure of urethral
mucosa to organisms in infected urine, preventing infectious urethritis that
produces dysuria, urgency in infected noncatheterized patients. A patent
urinary catheter ensures that urinary tract is continuously decompressed,
preventing urgency and frequency associated with distension of an inflamed
bladder and Vesicoureteral reflux [89]. Five of these patients had Pyelonephritis,
3 patients had Cystitis, and 19 patients had lower UTI(Table 4).
Most of the patients in our study belonged to Medical ward, contributing
to 35% of patients, followed by Nephrology (17%) (Table 5). This was similar
to the study by Stephen P storfer [90].The risk factors were also found to vary in
different wards. Diabetes mellitus was the most common risk factor in patients
from medical wards, CKD and other diseases of urinary tract were common in
Nephrology and Urology. ICU and surgery ward patients showed antibiotics
and catheterization as the common risk factors [87].
Antibiotic use (82%) and catheterization (73%) were the most common
risk factor associated (Table 6). This was lower than the results by Uma
Chaudary et al [91] ,who showed antibiotics as a risk factor in 99.6% of patients,
 
catheterization in 90%, because the study population in her study included
Critically Ill patients with Candiduria rather than the hospitalized patients in
our study. Antibiotics alter the normal flora of the genito-urinary tract, thus
paving way for colonization by Candida species. The surface of catheters also
aid in colonization with non albicans Candida spp .There was no statistically
significant association between nonalbicans Candida spp and antibiotic use,
with a ‘p’ value of 0.792.
Diabetes mellitus (43%) was most common disease associated, followed
by CKD (34%). This was slightly higher than the study by Cl´audia Castelo
Branco et al[93], who showed 26.7% of the patients, had diabetes probably
because; Indians are more prone to diabetes. India is termed as the “diabetes
capital of the world”. According to the Diabetes Atlas 2006 published by the
International Diabetes Federation, the number of people with diabetes in India
currently around 40.9 million is expected to rise to 69.9 million by 2025 due to
“Asian Indian Phenotype” refers to certain unique clinical and biochemical
abnormalities in Indians which includes increased insulin resistance, greater
abdominal adiposity, lower adiponectin and higher C-Reactive Protein levels.
[92]
Immuno suppressives like steroids (oral and injectable), tacrolimus and
mycophenolate mofetil were also important risk factors, as they alter the
natural immunity to Candida spp. These drugs were used as a therapy for
transplant recipients, neurosurgery patients and for patients with auto immune
diseases like SLE and RPGN. Unconsciousness was another risk factor, as
most of the patients were on prolonged indwelling catheter and prolonged
 
antibiotics. Transplant was an important risk factor and it showed a
statistically significant association with C.tropicalis Candiduria with a ‘p’
value of 0.002 by Chi-Square test.
CKD was the most common disease among the diseases of urinary tract,
contributing to 34% of the patient population (Table 7). It was higher than the
results obtained in the study by Stephen P storfer [90], where in 19% of patients
showed renal insufficiency and 18% in the study by S.Krcmery et al[5]. This
increase was probably because 18 of the 34 patients were diabetic. Glycosuria
and impaired functions of phagocytes in these patients are important factors
favouring colonization. Uremia in CKD patients and hemodialysis in these
patients, makes them more susceptible to infections. The predisposition is
attributed to impairments in lymphocyte and granulocyte function, circulating
inhibitors to chemotactic factors, frequent violation of skin and mucosal
barriers, iron overload, underlying disorders, low albumin levels and metabolic
acidosis. There was no statistically significant difference between C.albicans
and nonalbicans Candida spp. in CKD patients with a ‘p’ value of 0.211.Other
structural and anatomical abnormalities of Kidney, like Calculi, BPH,
Neurogenic bladder ,RPGN ,Hypospadiasis ,Phimosis and Carcinoma prostate
were found in 13% of patients , contributed to Candiduria due to the
obstruction and incomplete emptying of the bladder.
Among the type of urine samples obtained, catheterized samples
contributed to a total of 73% and midstream urine samples in 27% of
patients.(Table 8) This was comparable to the study by Cl´audia Castelo
Branco Artiaga Kobayashi et al [93] and study by Arlene O.Cantillep et al
 
[87]where in 84.4% and 89% of patients were catheterized. Catheterization was
described by many authors as the most important risk factor.
The present study showed predominance of non albicans Candida spp.
contributing to 86.7% of isolates and C.albicans contributing only 13.3% of the
isolates(Table 9). This was comparable to the results obtained by Manisha jain
et al[94], who showed non albicans Candida spp. as predominant isolate in
71.4% from urine isolates.
The species distribution was as follows, C.tropicalis in 63.8%,
C.albicans in 13.3%, C.guillermondii and C.krusei in 7.8% C.parapsilosis in
5.7% and C.kefyr in 1.9% (Table 10). This was also comparable to the results
by Manisha Jain et al [94] from north India. Her study showed 52.9% of isolates
as C.tropicalis and 29.8% as C.albicans. In contrast, the studies by Elza Helena
Da Silva et al[95] and N.Febre et al[96] from Brazil showed C.albicans as
predominant species contributing to about 56% and 46.15% respectively. An
increasing predominance of non-albicans Candida spp. was also noted in these
studies.
Mixtures were isolated from 5 urine samples and the rest of 95 were
single isolates. This was comparable to the results obtained by S.Agarwal et al
[97]
. C.tropicalis was the most common single isolate obtained, but the mixture
isolates showed a predominance of C.krusei found in all the mixtures, followed
by C.tropicalis (Table 11).This is a very interesting finding as C.krusei, more
resistant species was probably replacing the original species.
 
Non albicans Candida spp were common in both catheterized and mid
stream urine samples (Table 12). The asscociation between non albicans
Candida spp and catheterized patients was also highly significant with a ‘p’
value of 0.005 by Fischer’s Exact test. This is an important observation as
26.5% of catheter associated infections are due to fungi [98].
Biofilm formation of the C. tropicalis strain on the catheter surface may
contribute to the colonization in patients with urinary catheter. Biofilms of
C.tropicalis, with an extensive, hexosamine-rich matrix, were poorly
penetrated by antifungal agents, where as biofilms of C.albicans, with a less-
extensive glucose rich matrix, were more readily penetrated by drugs[99]. The
exact reason for the increase in non-albicans Candida spp. is incompletely
understood. C.albicans was found in 31.3% of the midstream samples but it
contributed to only in 6.6% in catheterized patients. C.albicans was more
common in midstream urine samples than catheterized patients and this
association was highly significant with a ‘p’ value of 0.03 by Chi-Square
test.
Assimilation was the best method of Candida speciation as it identified
all the Candida spp.(100%) and was taken as gold standard for species
identification [91], followed by fermentation. The ability of Hi-Chrom agar to
identify the species varied greatly from 86.5% to 100% in different
species(Table 13).Although there was no statistically significant difference
between Hi-Chrom agar and assimilation with a ‘p’ value of 0.421, sensitivity
of Hi-Chrom agar, the ability to identify true positive isolates varied between
species. It was 100% sensitive for C.parapsilosis, C.krusei, 92.8% sensitive for
 
C.albicans, less sensitive for C.tropicalis (86.5%) and C.guillermondii (87.5%)
(Table 14). Over all sensitivity of Chrom agar was 87.6%. This was
comparable to the results of Uma Chaudary et al[91], who showed Hi-Chrom
agar sensitivity of 88% -100% in different species of Candida. In contrast,
V.P.Baradhkar et al[49], showed the sensitivity of Hi-Chrom agar for
C.tropicalis was 100% compared to 86.5% in our study, probably because,
large number of C.tropicalis isolates were screened in our study.
Specificity, the ability of colours to identify true negative by Hi-Chrom
agar was 100% for C.parapsilosis, C.krusei, C.guillermondii and C.kefyr
,92.8% for C.albicans and 97.4 % for C.tropicalis. These results were
comparable to the study by V.P.Baradkar et al [49], who showed a specificity of
96.4% for C.albicans, 100% for C.tropicalis, 80% for C.parapsilosis. The
specificity for C.parapsilosis was higher in our study and studies on large
number of isolates of C.parapsilosis will probably solve the reasons for such
discrepancies.
Light green colonies was only 65% predictive for C.albicans ,as it gave
a lot of false positives. 98.3% of steel blue was predictive of C.tropicalis.
Cream colour, dry pink colonies and pale pink to purple colour was 100%
predictive for C.parapsilosis, C.krusei and C.guillermondii .(Table 15)
In the present study, Fluconazole resistance was observed in 22.4% of
C.tropicalis and 14.3% of C.albicans isolates by MBD and DD(Table 16).This
was comparable to the results obtained in the study by Ariane Bruder-
Nascimento et al[100], who showed resistance in 18.4% of isolates of
C.tropicalis and Rizvi MW et al[101] who showed 20% of resistant strains of
 
C.albicans. But C.albicans was highly sensitive in study by Ariane Bruder-
Nascimento et al[100], contrasting to the present study. Minor error, due to
discrepancies between DD and MBD ,the SDD isolates becoming sensitive or
vice-versa were observed in 3.8%, which is allowable error(Table 18). A. L.
Barry et al [102] also showed minor error of 5.7% in his study.
Itraconazole sensitivity was observed in 79.1% of isolates MBD, while
only 72.4% of isolates were susceptible by DD (Table 17). C.krusei and
C.tropicalis were more resistant to Itraconazole than other species. This was
comparable to the results by Ariane Bruder-Nascimento[100] et al, who showed
72.2% isolates were sensitive, with C.tropicalis being the most resistant. Minor
error of 11.4% and major error of 1.9% had occurred, due to discrepancies
between MBD and DD (Table 19). This shows that MBD was more reliable for
Itraconazole.
All the isolates were susceptible by MBD to Amphotericin B, but (table
18) DD showed that only 87.5% of isolates were susceptible and it was due to
major error of 13.3%. As it is not allowable, MBD should be relied for
Amphotericin B susceptibility. Similar results were obtained in a study by
Ariane Bruder-Nascimento et al. [100]
 
SUMMARY
• A total of 100 patients were included in the study, of which 27% of
patients were in the > 60 yrs group, followed by 19% of patients in 40-
49 and 50-59 yrs age group.
• Males constituted 56% and females 44% of the total population.
• The types of presentation varied as follows, asymptomatic in 42%,
symptomatic in 27% and unconsciousness (patients unable to voice
their symptoms) in 31% of patients.
• Fever (16%) and dysuria (11%), were the common symptoms in patients
with Candiduria.
• Prolonged antibiotics (82%), catheterization (73%), Diabetes mellitus
(43%), CKD(34%) were the common risk factors associated.
Catheterization is a significant predisposing factor for nonalbicans
Candida spp. Candiduria, ‘p’ =0.03 by Fisher’s Exact test.
• Transplant was a significant risk factor for C.tropicalis Candiduria,
‘p’=0.002 by Chi-Square test.
• Catheterized samples constituted 73% and mid-stream urine constituted
27% of total urine samples.
• C.albicans constituted 13.3% and nonalbicans Candida spp. constituted
86.7% of the total isolates obtained.
• C.tropicalis was isolated in 63.8%,C.guillermondii & C.krusei in
7.6%,C.parapsilosis in 5.7%,C.kefyr in 1.9% of the 105 isolates.
 
• 95% of samples yielded single isolates and 5% of samples yielded
mixture isolates. C.krusei was the predominant isolate found in
combination with other Candida spp in all the mixture.
• Sugar assimilation, though laborious was the best method of speciation
followed by sugar fermentation which takes longer time to interpret. Hi-
Chrom agar was a comfortable rapid method, though the sensitivity was
87.6%. It had a high positive predictive value for steel blue color
indicative of C.tropicalis, which is the most common species isolated.
• Resistance to Fluconazole was seen in 24.7% of isolates, with
C.tropicalis being the most resistant (68.7%).
• 79.1% isolates were sensitive to Itraconazole.
• 100% of the isolates were sensitive to Amphotericin B.
• DD can be used for Fluconazole, as minor error of only 3.8% occurred
due to discrepancies between DD and MBD.
• MBD is the best method for finding out Antifungal Susceptibility for
Itraconazole & Amphotericin B, as major errors occurred due to
discrepancies between the methods.
 
CONCLUSION
100 hospitalized patients in RAJIV GANDHI GOVERNMENT
GENRAL HOSPITAL, both males and females with Candiduria colony count
of 104 were included in the study and 105 Candida Spp were isolated. It
showed a predominance of non albicans Candida spp of about 86.7%.
C.tropicalis (63.8%) was the most common isolate obtained followed by
C.albicans (13.3%), C.krusei (7.6%), C.guillermondii (7.6%), C.parapsilosis
(5.7%) and C.kefyr (1.9%). C.krusei, intrinsically resistant to Fluconazole was
commonly isolated from mixtures. Indwelling urinary catheter was an
important associated risk factor for nonalbicans Candiduria. Multiple risk
factors like antibiotic therapy, prolonged catheterization, Diabetes, CKD and
hemodialysis were present in many patients.
Laborious procedure of sugar assimilation precludes its use. Hi-Chrom
agar takes only 48 hrs for species identification, and is a comfortable
alternative to conventional methods, that take 96-120 hrs. Hi-chrom agar is
superior to other conventional methods available for detection of mixtures. It is
good especially for urine samples, as steel blue color of C.tropicalis, the
predominant isolate, has a positive predictive value of 98.3%. It was also 100%
sensitive for C.krusei, the most resistant Candida isolate. 24.7% isolates were
resistant to Fluconazole and 12.4% to Itraconazole. But the positive predictive
 
value of light green color is only 65%, which can be overcome by combination
with sugar assimilation for improving the efficiency of species identification.
Constant surveillance of Candiduria is important as C.tropicalis is more
invasive, can lead to fatal Candidemia. Identification of Candida to species
level is essential, as it can give an idea to the Clinicians about empirical
therapy in emergency situations. Hi-Chrom agar helps in reducing the time for
diagnosis, thereby reducing the duration of hospital stay and the cost of
treatment. The rising antifungal resistance also demands Anti- Fungal
Susceptibility testing a routine in all Microbiology Laboratories due to
alarming increase of resistant fungal infection.
 
PROFORMA
¤ Name : IP no:
¤ Age: Ward:
¤ Sex:
¤ Occupation:
¤ Address
¤ Presenting complaints:
¤ Risk factors of the patients:
Underlying illness
Diabetes mellitus
Hypertension
Uremia
Any structural abnormality in urinary tract
Neoplasm
Coma
Pronged stay in ICU
Broad spectrum antibiotic, antifungal & its duration
Immunosuppressive therapy/Chemotherapy
Other candidiasis (oral/oesophageal etc)
Sepsis
Procedures
Duration & reason of catherization
Any invasive procedure in urinary tract
Transplant
 
Prior surgery
¤ Physical examination:
¤ laboratory evaluation:
Microbiological investigation:
Specimen:URINE
• Direct mount:
• Gram’s stain:
• Culture on SDA:
• Quantitative culture:
• Germ tube:
• Culture on Chrom Agar:
• Culture on Cornmeal Agar:
• Biochemical reactions:
• Sugar fermentation: Dextrose ,Lactose, Sucrose, Maltose
• Sugar assimilation: Dextrose ,Lactose, Sucrose, Trehalose, Raffinose
• Antifungal susceptibility pattern:
-Disk diffusion: Amphotericin B, Itraconazole & Fluconazole
-Microbroth dilution technique : Amphotericin B, Itraconazole &
Fluconazole
 
ABBREVIATIONS
AIDS - Acquired Immunodeficiency Syndrome
ATCC - American Type Culture Collections
BPH - Benign Prostatic Hypertrophy
Ca - Carcinoma
CLSI - Clinical Laboratory Standards Institute
CIE - Counter immune Electrophoresis
CLED agar - Cystine Lactose Electrolyte Deficient agar
DD - Disk Diffusion Method
DMSO - Dimethyl Sulfoxide
DNA - Deoxy Ribonucleic Acid
ELISA - Enzyme Linked Immune Sorbent Assay
EUCAST - European Committee for Antimicrobial
Susceptibility Testing
HIV - Human Immunodeficiency Virus
ICU - Intensive Care Unit
ID - Immuno-diffusion
 
LA - Latex Agglutination
LPCB - Lacto Phenol Cotton Blue
MBD - Microbroth Dilution Technique
MHA - Mueller Hinton Agar
MIC - Minimum Inhibitory Concentration
MOPS - 3N-Morphilino Propane Sulphonic Acid
PCR - Polymerase Chain Reaction
QC - Quality Control
RNA - Ribo Nucleic Acid
RPGN - Rapid Proliferative Glomerulonephritis
RPMI - Rosewell Park Memorial Institute
SDA - Sabouraud’s Dextrose Agar
SDD - Susceptible Dose Dependent
UTI - Urinary Tract Infection
YNB - Yeast Nitrogen Base
 
APPENDIX
GRAM’S STAINING:
Methyl violet(2%)-10 g, Methyl violet in 100 ml absolute alcohol in
1litre of distilled water (primary stain)
Gram’s iodine- 10g iodine in 20g KI (fixative)
Acetone- Decolorizing agent
Dilute Carbol Fuschin (1%)-(Secondary stain)
BLOOD AGAR:
Peptone-10gm
Nacl-5gm
Distilled water-1litre
Agar-10gm
Dissolve in distilled water by boiling. Cool to at 55 ºC and add 5%
sterile sheep blood . Adjust pH to 7.4.
CLED AGAR (Cystine Lactose Electrolyte Deficient Agar)
Peptone -4gm/l
Tryptone -4gm/l
Meat extract powder-3g/l
Lactose-10g/l
L-cystine-0.128g/l
Bromothymol blue-0.02g/l
Agar-15g/l
Water-1litre
Suspend the ingredients in water, bring to boil and dissolve. Sterilize at
121ºC for 15 min and mix well before pouring.
SABOURAD’S DEXTROSE AGAR WITH ANTIBIOTICS:
Peptone-10gm
Dextrose-40gm
 
Agar-20gm
Distilled water-1000ml
Chloramphenicol-50 mg
Final pH adjusted to 5.6
The above ingredients were reconstituted in one litre of distilled
water.Dissolve the powder in distilled water by boiling.Dissolve
chloramphenicol in 10 ml of 95% alcohol and added to boiling
medium.The medium was then removed from heating, mixed well and
then dispersed in tubes and autoclaved at 121ºC for 15 minutes. The
final pH was adjusted to 5.6.The tubes were cooled in slanted position.
CHROM AGAR/ Hi-Chrom Candida Differential Agar:
Hi-veg special peptone-15 gm/l
Yeast extract-4gm/l
Dipotassium hydrogen phosphate-1gm/l
Chromogenic mixture-7.22gm/l
Chloramphenicol-0.50gm/l
Agar -15gm/l
pH-6.3+ 0.2
Suspend 42.72grams in 1litre of distilled water.Heat to boiling to
dissolve the medium completely. Cool the medium to 50 ºC and pour
into sterile petri dishes.
CORNMEAL TWEEN 80 AGAR:
Cornmeal-50gm/l
Agar-15gm/l
Distilled water-1litre
Tween 80(1%) -3ml/l
Suspend the ingredients in 1 litre of distilled water and boiled to
dissolve completely. Tween 80 should be added to the above medium. It
is sterilized by autoclaving at 121 ºC for 15 minutes.
 
YEAST NITROGEN BASE AGAR MEDIUM:
Ingredients Grams/l Ingredients Grams/l
Ammonium Sulphate
L-Histidine
Hydrochloride
DL-Methionine
DL-Tryptophan
Biotin
Calcium Pantothene
Folic acid
Inositol
Niacin
Para amino benzoic acid
Pyridoxine
hydrochloride
Riboflavin
5.00
0.01
0.02
0.02
0.000002
0.00004
0.000002
0.02
0.0004
0.0002
0.0004
0.0002
Thiamine hydrochloride
Boric acid
Copper sulphate
Potassium iodide
Ferric chloride
Manganese chloride
Sodium molybdate
Zinc sulphate
Monopotassium
phosphate
Magnesium sulphate
Sodium chloride
Calcium chloride
0.004
0.0005
0.00004
0.0001
0.0002
0.0004
0.0002
0.0004
1.00
0.50
0.10
0.10
Dissolve 6.7 gms of the media in 100ml of distilled water.Sterilize by
filtration and store at 4ºC.
CARBOHYDRATE FERMENTATION MEDIA:
Peptone- 15gm/l
Sugar to be tested-20gm/l
Nacl-5gm/l
Distilled water-1litre
Dissolve the peptone, Bromothymol blue indicator and sodium chloride
in 1000ml of distilled water and 20 gms of the sugar to be tested.
Distribute approx 5 ml in sterile test tubes containing an inverted
Durham’s (gas production). Sterilize by autoclaving at 10 pounds
pressure.
MUELLER HINTON AGAR
Beef infusion-300ml
Casein hydrolysate-17.5gm
Starch-1.5gm
Agar-10gm
Distilled water-1000ml
 
pH-7.4
Sterilize by autoclaving 121ºC for 20 minutes.
RPMI 1640(ROSEWELL PARK MEMORIAL INSTITUTE) MEDIA:
RPMI MEDIUM-10.4gm
MOPS buffer-34.43gm
Dissolve powdered medium in 900ml distilled water. Add MOPS to a
final concentration of 0.165 mol/L and stir until dissolved. While stirring,
adjust the pH to 7.0 at 25ºC. Add additional water to bring medium to a final
volume of 1000ml. Filter sterilize and store at 4 ºC. 
X Mc farland’s 0.5 turbidity standard
• Prepare this turbidity standard by adding 0.5ml of 1.175% Bacl2
to 99.5ml of H2SO4 with constant stirring to maintain a
suspension.
• Verify the correct density of the turbidity standard by using a
spectrophotometer. The absorbance at 625nm should be 0.08 to
0.10 for the 0.5Mc Farland standard.
• Distribute 4 to 6 ml into screw capped tubes and tightly seal the
tubes and store them in the dark at room temperature.
• Vigorously agitate this turbidity standard on a mechanical vortex
just before use.
SUGAR ASSIMILATION PATTERN:
SPECIES D L S C R
Candida tropicalis + - + + -
Candida albicans + - + - -
Candida parapsilosis + - + - -
Candida krusei + - - - -
Candida
guillermondii
+ - + + +
Candida kefyr + + + +(v) +
Candida glabrata - - - - -
 
(Fisher and Cook-Fundamentals of Diagnostic Mycology)
D-Dextrose, L-Lactose, S-Sucrose ,C-Cellobiose, R-Raffinose
SUGAR FERMENTATION PATTERN:
SPECIES G L M S
Candida tropicalis + - + +
Candida albicans + - + -
Candida parapsilosis + - - -
Candida krusei + - - -
Candida guillermondii + - - +
Candida kefyr + - + +
Candida glabrata + - - -
(Jagdish Chander-Textbook of Medical Mycology)
G-Glucose, L-Lactose, M-Maltose, S-Sucrose
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“A STUDY ON URINARY ISOLATES OF CANDIDA SPECIES ISOLATED
FROM HOSPITALIZED PATIENTS WITH SPECIAL REFERENCE TO
SPECIATION, ANTIFUNGAL SUSCEPTIBILITY AND COMPARISON OF
RAPID AND CONVENTIONAL METHODS OF SPECIATION”
Abstract
INTRODUCTION:
Candida are a part of human microbial flora .Although ubiquitous in
nature, they can also cause various infections primarily in hospitalized patients.
They are the most prevalent opportunistic fungal pathogens involving urinary
tract, presenting mostly as nosocomial infection rather than community acquired
infection.10-15% of nosocomial urinary tract infections are due to Candida and it
also correlates with invasive disease significantly. As there is a sudden increase of
non-albicans Candida spp, the present study was conducted to determine the
species of Candida isolated from the urine of hospitalized patients, to correlate
risk factors associated and to find out the antifungal susceptibility of the Candida
species isolated.
AIMS AND OBJECTIVES:
• To speciate Candida isolates from urine of hospitalized patients , correlate the risk
factors associated and to find Antifungal Susceptibility pattern.
• To compare the rapid method like Chrom agar for speciation with conventional
methods of speciation.
MATERIALSAND METHODS:
The study was done on Hospitalized Patients both males and females, older than
12 yrs of age with urine colony count of any Candida species more than or equal to 10
4/ml. After, primary isolation of Candida spp. on Sabouraud’s Dextrose agar, they were
speciated using chrom agar, cornmeal agar, sugar fermentation and sugar assimilation
tests. Antifungal susceptibility was done by Kirby-Bauer’s disk diffusion method and
microbroth dilution technique and interpreted according to CLSI guidelines.
RESULTS:
Majority of patients belonged to above 60yrs group (27%) , as they had more risk
factors than others.73% of Candiduria patients were catheterized, and catheterization
promoted the colonization of non-albicans Candida species significantly. Prolonged
antibiotics and catheterization were the most common risk factors, Diabetes was the most
common disease as glycosuria contributed to their colonization.
C.tropicalis contributed to 63.8%, followed by C.albicans (13.3%) but mixtures
showed a predominance of C.krusei, a highly resistant species.Hi- Chrom agar was able
to identify 87.5% of the isolates. It has huge advantage of early speciation and simple
technique, hence can be done for routine speciation combined with conventional
technique whenever discrepancies arise.24.8% of isolates were resistant to Fluconazole
and 12.4% to Itraconazole. All the isolates were susceptible to Amphotericin B.
CONCLUSION:
Constant surveillance of Candiduria and eradication is important as it is more
invasive, leading to fatal Candidemia. Identification of Candida to species level can give
information to Clinicians about empirical therapy. Hi-Chrom agar , helps in reducing
time for diagnosis, thereby reducing duration of hospital stay and cost of treatment. The
rising antifungal resistance also demands Anti- Fungal Susceptibility testing a routine in
Microbiology Laboratories.
KEY WORDS: Candiduria, non-albicans Candida species, Chrom agar ,Anti- Fungal
Susceptibility.
